{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:47:33Z","timestamp":1791820053469,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejphar.2026.179176","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:13:36Z","timestamp":1784906016000},"page":"179176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Canagliflozin improves early-stage cardiac hypertrophy and energy metabolism in TAC mice"],"prefix":"10.1016","volume":"1031","author":[{"given":"Yumei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6562-6055","authenticated-orcid":false,"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanna","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-467X","authenticated-orcid":false,"given":"Wei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179176_bib1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+\/H+ exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2026.179176_bib2","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1021\/acs.jproteome.4c00142","article-title":"Characteristics of myocardial structure and central carbon metabolism during the early and compensatory stages of cardiac hypertrophy","volume":"23","author":"Chen","year":"2024","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejphar.2026.179176_bib3","article-title":"The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure","volume":"33","author":"Cluntun","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2026.179176_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1379236","article-title":"Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy","volume":"15","author":"Coleman","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179176_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104556","article-title":"The circadian clock remains intact, but with dampened hormonal output in heart failure","volume":"91","author":"Crnko","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2026.179176_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/HYPERTENSIONAHA.119.13437","article-title":"Future of hypertension","volume":"74","author":"Dzau","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2026.179176_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/HYPERTENSIONAHA.123.21710","article-title":"Precision hypertension","volume":"81","author":"Dzau","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2026.179176_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s10020-018-0005-x","article-title":"Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction","volume":"24","author":"Fillmore","year":"2018","journal-title":"Mol Med"},{"key":"10.1016\/j.ejphar.2026.179176_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7150\/thno.13624","article-title":"Imalytics preclinical: interactive analysis of biomedical volume data","volume":"6","author":"Gremse","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2026.179176_bib10","article-title":"An effective sodium-dependent glucose transporter 2 inhibition, Canagliflozin, prevents development of hypertensive heart failure in dahl salt-sensitive rats","volume":"13","author":"He","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179176_bib11","doi-asserted-by":"crossref","DOI":"10.3310\/hta21020","article-title":"Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation","volume":"21","author":"Johnston","year":"2017","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ejphar.2026.179176_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150595","article-title":"YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload","volume":"132","author":"Kashihara","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.179176_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00395-025-01123-y","article-title":"AAV-mediated overexpression of CPT1B protects from cardiac hypertrophy and heart failure in a murine pressure overload model","volume":"120","author":"Kliesow Remes","year":"2025","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179176_bib14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.109.914911","article-title":"Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes","volume":"121","author":"Kohlhaas","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179176_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvr071","article-title":"Glucose metabolism and cardiac hypertrophy","volume":"90","author":"Kolwicz","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.179176_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13020-022-00616-5","article-title":"Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia\/reperfusion injury","volume":"17","author":"Li","year":"2022","journal-title":"Chin. Med."},{"key":"10.1016\/j.ejphar.2026.179176_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010926","article-title":"Metabolic changes in spontaneously hypertensive rat hearts precede cardiac dysfunction and left ventricular hypertrophy","volume":"8","author":"Li","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2026.179176_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015154","article-title":"Metformin improves cardiac metabolism and function, and prevents left ventricular hypertrophy in spontaneously hypertensive rats","volume":"9","author":"Li","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2026.179176_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.molimm.2018.10.001","article-title":"Periodontal ligament fibroblasts migration injury via ROS\/TXNIP\/Nlrp3 inflammasome pathway with Porphyromonas gingivalis lipopolysaccharide","volume":"103","author":"Lian","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.179176_bib20","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.179176_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179176_bib22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0735-1097(01)01792-2","article-title":"Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction","volume":"39","author":"Norton","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179176_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10741-018-9669-0","article-title":"Clinical impact of oral antidiabetic medications in heart failure patients","volume":"23","author":"Palazzuoli","year":"2018","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ejphar.2026.179176_bib24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0735-1097(01)01790-9","article-title":"Pressure overload hypertrophy and congestive heart failure. Where is the \"Achilles' heel\"?","volume":"39","author":"Peterson","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179176_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104863","article-title":"Exogenous NADPH exerts a positive inotropic effect and enhances energy metabolism via SIRT3 in pathological cardiac hypertrophy and heart failure","volume":"98","author":"Qian","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2026.179176_bib26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajh.2008.16","article-title":"Left ventricular hypertrophy and clinical outcomes in hypertensive patients","volume":"21","author":"Ruilope","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2026.179176_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCHEARTFAILURE.114.001151","article-title":"Metabolomic analysis of pressure-overloaded and infarcted mouse hearts","volume":"7","author":"Sansbury","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejphar.2026.179176_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.004796","article-title":"Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart","volume":"2","author":"Sen","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2026.179176_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179176_bib30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41591-022-01703-8","article-title":"The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial","volume":"28","author":"Spertus","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.179176_bib32","article-title":"Canagliflozin combined with aerobic exercise protects against chronic heart failure in rats","volume":"27","author":"Sun","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.ejphar.2026.179176_bib31","article-title":"Chicoric acid ameliorates sepsis-induced cardiomyopathy via regulating macrophage metabolism reprogramming","volume":"123","author":"Sun","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.179176_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41440-021-00665-7","article-title":"Hypertension in diabetes care: emerging roles of recent hypoglycemic agents","volume":"44","author":"Tanaka","year":"2021","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2026.179176_bib34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.apsb.2024.11.001","article-title":"Reversing metabolic reprogramming by CPT1 inhibition with etomoxir promotes cardiomyocyte proliferation and heart regeneration via DUSP1 ADP-ribosylation-mediated p38 MAPK phosphorylation","volume":"15","author":"Tang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2026.179176_bib35","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","article-title":"Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+\/H+ exchanger, lowering of cytosolic Na+ and vasodilation","volume":"61","author":"Uthman","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2026.179176_bib36","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179176_bib37","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.2147\/DDDT.S421894","article-title":"The anti-inflammatory mediator 17(R)-Resolvin D1 attenuates pressure overload-induced cardiac hypertrophy and fibrosis","volume":"17","author":"Wang","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2026.179176_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ebiom.2018.08.022","article-title":"TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice","volume":"36","author":"Wang","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2026.179176_bib39","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCHEARTFAILURE.112.000228","article-title":"Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy","volume":"6","author":"Zhang","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejphar.2026.179176_bib40","article-title":"Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression","author":"Zhao","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2026.179176_bib41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2967\/jnumed.112.108092","article-title":"Quantitative PET imaging detects early metabolic remodeling in a mouse model of pressure-overload left ventricular hypertrophy in vivo","volume":"54","author":"Zhong","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejphar.2026.179176_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155717","article-title":"Qiangxinyin formula protects against isoproterenol-induced cardiac hypertrophy","volume":"130","author":"Zhou","year":"2024","journal-title":"Phytomedicine"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:18:32Z","timestamp":1786652312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926006588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"alternative-id":["S0014299926006588"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179176","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canagliflozin improves early-stage cardiac hypertrophy and energy metabolism in TAC mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179176"}}